Elisabetta Valoti

1.7k total citations
21 papers, 1.2k citations indexed

About

Elisabetta Valoti is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Elisabetta Valoti has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 16 papers in Nephrology and 10 papers in Hematology. Recurrent topics in Elisabetta Valoti's work include Complement system in diseases (19 papers), Renal Diseases and Glomerulopathies (16 papers) and Adenosine and Purinergic Signaling (5 papers). Elisabetta Valoti is often cited by papers focused on Complement system in diseases (19 papers), Renal Diseases and Glomerulopathies (16 papers) and Adenosine and Purinergic Signaling (5 papers). Elisabetta Valoti collaborates with scholars based in Italy, France and United Kingdom. Elisabetta Valoti's co-authors include Marina Noris, Elena Bresin, Giuseppe Remuzzi, Marta Alberti, Véronique Frémeaux‐Bacchi, Rossella Piras, Santiago Rodrı́guez de Córdoba, Roberta Donadelli, Serena Bettoni and Sara Gastoldi and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Frontiers in Immunology.

In The Last Decade

Elisabetta Valoti

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Valoti Italy 13 1.1k 844 429 176 157 21 1.2k
Rossella Piras Italy 13 1.1k 1.0× 908 1.1× 418 1.0× 216 1.2× 147 0.9× 24 1.3k
Marie-Alice Macher France 7 1.2k 1.1× 965 1.1× 545 1.3× 151 0.9× 159 1.0× 8 1.4k
Sheila Pinto Spain 13 911 0.8× 664 0.8× 402 0.9× 129 0.7× 120 0.8× 20 1.0k
Ramona Maranta Italy 5 717 0.7× 531 0.6× 263 0.6× 171 1.0× 208 1.3× 5 960
Gaia Pianetti Italy 6 1.6k 1.5× 1.1k 1.3× 643 1.5× 334 1.9× 253 1.6× 7 1.7k
Simona Brioschi Italy 5 863 0.8× 535 0.6× 401 0.9× 148 0.8× 181 1.2× 7 961
Kirsten L. Rose United Kingdom 6 678 0.6× 394 0.5× 227 0.5× 57 0.3× 92 0.6× 7 742
Claire Hall United Kingdom 6 575 0.5× 328 0.4× 296 0.7× 98 0.6× 201 1.3× 6 692
Isabel Y. Pappworth United Kingdom 11 703 0.7× 349 0.4× 284 0.7× 76 0.4× 62 0.4× 25 790
Dineke Westra Netherlands 15 451 0.4× 311 0.4× 199 0.5× 86 0.5× 69 0.4× 43 725

Countries citing papers authored by Elisabetta Valoti

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Valoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Valoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Valoti more than expected).

Fields of papers citing papers by Elisabetta Valoti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Valoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Valoti. The network helps show where Elisabetta Valoti may publish in the future.

Co-authorship network of co-authors of Elisabetta Valoti

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Valoti. A scholar is included among the top collaborators of Elisabetta Valoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Valoti. Elisabetta Valoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piras, Rossella, Elisabetta Valoti, Marta Alberti, et al.. (2023). CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome. Frontiers in Immunology. 13. 1011580–1011580. 9 indexed citations
2.
Valoti, Elisabetta, Rossella Piras, Caterina Mele, et al.. (2022). <b><i>Mycoplasma pneumoniae</i></b> Infection Associated with Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome. ˜The œNephron journals/Nephron journals. 146(6). 593–598. 2 indexed citations
3.
Piras, Rossella, Matteo Breno, Elisabetta Valoti, et al.. (2021). CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis. Frontiers in Genetics. 12. 670727–670727. 16 indexed citations
4.
Piras, Rossella, Paraskevas Iatropoulos, Elena Bresin, et al.. (2020). Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant. Frontiers in Medicine. 7. 579418–579418. 9 indexed citations
5.
Valoti, Elisabetta, Marta Alberti, Matteo Breno, et al.. (2019). Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association. ˜The œNephron journals/Nephron journals. 142(3). 264–270. 2 indexed citations
6.
Valoti, Elisabetta, Marta Alberti, Paraskevas Iatropoulos, et al.. (2019). Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS. Frontiers in Immunology. 10. 853–853. 29 indexed citations
7.
Galbusera, Miriam, Marina Noris, Sara Gastoldi, et al.. (2019). An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome. American Journal of Kidney Diseases. 74(1). 56–72. 65 indexed citations
8.
Valoti, Elisabetta, Marina Noris, Annalisa Perna, et al.. (2019). Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes. Frontiers in Genetics. 10. 681–681. 9 indexed citations
9.
Donadelli, Roberta, Rossella Piras, Paraskevas Iatropoulos, et al.. (2018). Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN. Frontiers in Immunology. 9. 2329–2329. 37 indexed citations
10.
Iatropoulos, Paraskevas, Erica Daina, Rossella Piras, et al.. (2017). Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN. Journal of the American Society of Nephrology. 29(1). 283–294. 83 indexed citations
11.
Iatropoulos, Paraskevas, Marina Noris, Caterina Mele, et al.. (2016). Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. Molecular Immunology. 71. 131–142. 115 indexed citations
12.
Mele, Caterina, Mathieu Lemaire, Paraskevas Iatropoulos, et al.. (2015). Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome. Clinical Journal of the American Society of Nephrology. 10(6). 1011–1019. 37 indexed citations
13.
Schramm, Elizabeth C., Lubka T. Roumenina, Tania Rybkine, et al.. (2015). Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood. 125(15). 2359–2369. 87 indexed citations
14.
Valoti, Elisabetta, Marta Alberti, Agustín Tortajada, et al.. (2014). A Novel Atypical Hemolytic Uremic Syndrome–Associated Hybrid CFHR1/CFH Gene Encoding a Fusion Protein That Antagonizes Factor H–Dependent Complement Regulation. Journal of the American Society of Nephrology. 26(1). 209–219. 84 indexed citations
15.
Bresin, Elena, Erica Rurali, Jessica Caprioli, et al.. (2013). Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype. Journal of the American Society of Nephrology. 24(3). 475–486. 263 indexed citations
16.
Manenti, Lucio, Augusto Vaglio, L Allegri, et al.. (2013). Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrology Dialysis Transplantation. 28(9). 2246–2259. 62 indexed citations
17.
Alberti, Marta, Elisabetta Valoti, Rossella Piras, et al.. (2013). Two Patients With History of STEC-HUS, Posttransplant Recurrence and Complement Gene Mutations. American Journal of Transplantation. 13(8). 2201–2206. 40 indexed citations
18.
Valoti, Elisabetta, Elena Bresin, Rossella Piras, et al.. (2013). Prevalence of C3 mutations in primary membranoproliferative glomerulonephritis. Molecular Immunology. 56(3). 255–255. 1 indexed citations
19.
Valoti, Elisabetta, Marta Alberti, & Marina Noris. (2012). Posttransplant recurrence of atypical hemolytic uremic syndrome. Journal of Nephrology. 25(6). 911–917. 6 indexed citations
20.
Vitulo, Patrizio, et al.. (1998). [A case of occupational pulmonary siderosis: the pathogenetic and prognostic considerations].. PubMed. 19(2). 50–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rossella Piras Breakdown of academic impact, for papers by Marie-Alice Macher Breakdown of academic impact, for papers by Sheila Pinto Breakdown of academic impact, for papers by Ramona Maranta Breakdown of academic impact, for papers by Gaia Pianetti Breakdown of academic impact, for papers by Simona Brioschi Breakdown of academic impact, for papers by Kirsten L. Rose Breakdown of academic impact, for papers by Claire Hall Breakdown of academic impact, for papers by Isabel Y. Pappworth Breakdown of academic impact, for papers by Dineke Westra
Rankless by CCL
2026